6gk5

From Proteopedia
Jump to navigation Jump to search

Crystal structure of cytochrome P450 CYP267B1 from Sorangium cellulosum So ce56Crystal structure of cytochrome P450 CYP267B1 from Sorangium cellulosum So ce56

Structural highlights

6gk5 is a 1 chain structure with sequence from Polyangium cellulosum (strain so ce56). Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:
Gene:cypA6, sce7167 (Polyangium cellulosum (strain So ce56))
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Publication Abstract from PubMed

Oxidative biocatalytic reactions performed by cytochrome P450 enzymes (P450s) are of high interest for the chemical and pharmaceutical industries. CYP267B1 is a P450 enzyme from myxobacterium Sorangium cellulosum So ce56 displaying a broad substrate scope. In this work, a search for new substrates was performed, combined with product characterization, and a structural analysis of substrate-bound complexes using X-ray crystallography and computational docking. The results demonstrate the ability of CYP267B1 to perform in-chain hydroxylations of medium-chain saturated fatty acids (decanoic acid, dodecanoic acid and tetradecanoic acid) and a regioselective hydroxylation of flavanone. The fatty acids are mono-hydroxylated at different in-chain positions, with decanoic acid displaying the highest regioselectivity towards omega-3 hydroxylation. Flavanone is preferably oxidized to 3-hydroxyflavanone. High-resolution crystal structures of CYP267B1 revealed a very spacious active site pocket, similarly to other P450s able to convert macrocyclic compounds. The pocket becomes more constricted near to the heme, and is closed off from solvent by residues of the FG helices and the B-C loop. The crystal structure of the tetradecanoic acid-bound complex displays the fatty acid bound near to the heme, but in a non-productive conformation. Molecular docking allowed modeling of the productive binding modes for the four investigated fatty acids and flavanone, as well as of two substrates identified in a previous study (diclofenac and ibuprofen), explaining the observed product profiles. The obtained structures of CYP267B1 thus serve as a valuable prediction tool for substrate hydroxylations by this highly versatile enzyme and will encourage future selectivity changes by rational protein engineering.

Structural insights into oxidation of medium-chain fatty acids and flavanone by myxobacterial cytochrome P450 CYP267B1.,Jozwik IK, Litzenburger M, Khatri Y, Schifrin A, Girhard M, Urlacher V, Thunnissen AWH, Bernhardt R Biochem J. 2018 Jul 25. pii: BCJ20180402. doi: 10.1042/BCJ20180402. PMID:30045877[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Jozwik IK, Litzenburger M, Khatri Y, Schifrin A, Girhard M, Urlacher V, Thunnissen AWH, Bernhardt R. Structural insights into oxidation of medium-chain fatty acids and flavanone by myxobacterial cytochrome P450 CYP267B1. Biochem J. 2018 Jul 25. pii: BCJ20180402. doi: 10.1042/BCJ20180402. PMID:30045877 doi:http://dx.doi.org/10.1042/BCJ20180402

6gk5, resolution 1.60Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA